Old Web
English
Sign In
Acemap
>
authorDetail
>
Takuko Yamada-Sawada
Takuko Yamada-Sawada
Medicine
Pharmacology
Matrix metalloproteinase inhibitor
Cancer research
Cancer
5
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers
2007
British Journal of Clinical Pharmacology
Timothy Mant
Daniel Bradford
Dipti Amin
Jaya Pisupati
Yoshikazu Kambayashi
Yoshitaka Yano
Kazushige Tanaka
Takuko Yamada-Sawada
Show All
Source
Cite
Save
Citations (7)
A phase I pharmacokinetic and pharmacodynamic study of S-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors
2007
Clinical Cancer Research
Alberto Chiappori
S. Gail Eckhardt
Ronald M. Bukowski
Daniel M. Sullivan
Minoru Ikeda
Yoshitaka Yano
Takuko Yamada-Sawada
Yoshikaze Kambayashi
Kazushige Tanaka
Milind Javle
Tarek Mekhail
Cindy L. O'Bryant
Patrick J. Creaven
Show All
Source
Cite
Save
Citations (37)
CP8-7 Antitumor effect of MMP Inhibitors
2004
The Japanese Journal of Urology
Kazushige Tanaka
Yoshikazu Kambayashi
Takayuki Yoshioka
Takuko Yamada-Sawada
Show All
Source
Cite
Save
Citations (0)
Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents
2002
Anticancer Research
Kanji Hojo
Hideo Maki
Takuko Yamada-Sawada
Ryuji Maekawa
Takayuki Yoshioka
Show All
Source
Cite
Save
Citations (5)
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
2002
Clinical & Experimental Metastasis
Hideo Maki
Kanji Hojo
Hidekazu Tanaka
Takuko Yamada-Sawada
Ryuji Maekawa
Takayuki Yoshioka
Show All
Source
Cite
Save
Citations (10)
1